Home » Clinical development » Advancing Repurposed Therapeutics for Epidermolysis Bullosa (ART-EB)
Advancing Repurposed Therapeutics for Epidermolysis Bullosa (ART-EB)

Research area:

Rare disease

Disease:

Epidermolysis Bullosa

Intervention:

Therapeutics – large molecules/biologics

Phase:

Phase II/III

Funding awarded to

Dr Su Lwin, Kings College London